|
3160
|
Azelnidipine
|
Calcium channel blocker |
€70.00 |
|
3181
|
BI 99179
|
Potent, selective and orally active inhibitor of type I fatty acid synthase (FAS) |
€150.00 |
|
3182
|
BI 99990
|
Negative control of BI 99179 as a selective inhibitor of type I fatty acid synthase |
€130.00 |
|
3148
|
BPN14770
|
Potent, selective, allosteric inhibitor of PDE4D |
€120.00 |
|
3156
|
Centhaquin
|
Centrally acting hypotensive agent |
€90.00 |
|
3141
|
DHQZ 36
|
Potent retrograde trafficking inhibitor |
€120.00 |
|
3094
|
GLPG1690
|
First-in-class, potent ATX inhibitor |
€110.00 |
|
3030
|
JNJ0966
|
Highly selective pro-MMP9 activation inhibitor |
€80.00 |
|
3185
|
L651582
|
Ca2+ channel blocker |
€120.00 |
|
3079
|
NPB
|
Potent, site-specific Bcl-2-associated death promoter (BAD) inhibitor |
€130.00 |
|
3158
|
Otilonium bromide
|
Ca2+ channel blocker |
€70.00 |
|
3034
|
PI-273
|
Substrate-competitive, subtype-specific inhibitor of PI4KIIα |
€120.00 |
|
3093
|
Risdiplam
|
Selective SMN2 gene splicing modifier |
€140.00 |
|
3195
|
Selpercatinib
|
Potent, highly selective, and ATP-competitive RET inhibitor |
€110.00 |
|
3082
|
SIC5-6
|
Specific, noncovalent separase inhibitor |
€110.00 |
|
3119
|
Stiripentol
|
PAM of GABAA |
€70.00 |
|
3130
|
Tandospirone citrate
|
5-HT1A partial agonist |
€90.00 |
|
3149
|
TC11
|
Anti-tumor agent; Apoptosis inducer |
€110.00 |
|
3076
|
TJ191
|
Potent and selective anti-cancer agent targeting low TβRIII-expressing malignant T-cell leukemia/lymphoma cells |
€120.00 |
|
3078
|
TUG-1375
|
Potent GPR43 receptor agonist (FFA2) |
€180.00 |